Discontinuation criteria
cardiovascular and cerebrovascular emergencies, mental illness, seizures, allergies
STATUS EPILEPTICUS, ADVERSE EVENTS, ADVERSE EVENT, CARDIAC ARREST, ALLERGIES
Judgment according to the researchers.
Serious adverse events occur during the trial including severe cardiovascular and cerebrovascular emergencies, seizures with cardiac arrest, status epilepticus, or other symptoms of serious mental illness.Adverse events occur during the trial, including allergies to antiplatelet drugs and intolerable side effects.Participants who seriously violate the protocol.Active withdrawal of the participants.Reasons for active withdrawal from the trial include serious and common adverse events, loss to follow-up, and withdrawal of informed consent. Participants have the right to withdraw from the trial at any time and for any reason. To provide sufficient materials for the statistical analysis of this trial, when a participant decides to withdraw, the researchers will make efforts to complete the final examination, including recording follow-up information, arranging relevant clinical examinations, and documenting the eCRF. Detailed baseline information on participants and reasons for withdrawal shall be recorded in the eCRFs.